Marit Liland Sandvold
- Physiology top 5%
- Adenosine and Purinergic Signaling 3
-
- Drug Transport and Resistance Mechanisms 4
- Biomaterials top 10%
- Hematology top 10%
-
- Cancer therapeutics and mechanisms 6
- Biochemical and Molecular Research 5
- Epigenetics and DNA Methylation 3
-
- HIV/AIDS drug development and treatment 7
-
- Cytomegalovirus and herpesvirus research 4
-
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Godefridus J. PetersFinn MyhrenHans R. HendriksAndries M. BergmanWenche RaschØystein FodstadIduna FichtnerFrank Lyko
- Cited by
- PhysiologyOncologyBiomaterials
- Journals
- Nucleosides Nucleotides & Nucleic Acids (5 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- NetherlandsNorwayUnited Kingdom
In The Last Decade
Marit Liland Sandvold
27 papers receiving 702 citations
Peers
Comparison fields: 5 of 82
- Physiology 54
- Oncology 222
- Biomaterials 96
- Hematology 80
- Molecular Biology 462
Countries citing papers authored by Marit Liland Sandvold
This map shows the geographic impact of Marit Liland Sandvold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Liland Sandvold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Liland Sandvold more than expected).
Fields of papers citing papers by Marit Liland Sandvold
This network shows the impact of papers produced by Marit Liland Sandvold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Liland Sandvold. The network helps show where Marit Liland Sandvold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marit Liland Sandvold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 41 | |
| 2 | 2013 | 1 | |
| 3 | 2011 | 42 | |
| 4 | 2011 | 13 | |
| 5 | 2010 | 78 | |
| 6 | 2010 | 15 | |
| 7 | 2010 | 12 | |
| 8 | 2009 | 19 | |
| 9 | 2009 | 115 | |
| 10 | 2008 | 27 | |
| 11 | 2008 | 26 | |
| 12 | Antitumor activity of CP-4055 is enhanced in combination with bevacizumab, cetuximab, and trastuzumab in human NSCLC xenografts | 2007 | 2 |
| 13 | 2004 | 22 | |
| 14 | 2004 | 25 | |
| 15 | 2004 | 1 | |
| 16 | 2003 | 73 | |
| 17 | 2000 | 14 | |
| 18 | 1999 | 8 | |
| 19 | 1998 | 23 | |
| 20 | 1985 | 25 |
About Marit Liland Sandvold
Marit Liland Sandvold is a scholar working on Physiology, Oncology, Infectious Diseases, Genetics and Molecular Biology, having authored 27 papers that have together received 725 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), Cancer therapeutics and mechanisms (6 papers), Biochemical and Molecular Research (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Adenosine and Purinergic Signaling (3 papers). The work is most often cited by research in Physiology (54 citations), Oncology (222 citations), Biomaterials (96 citations), Hematology (80 citations) and Molecular Biology (462 citations). Marit Liland Sandvold has collaborated with scholars based in Netherlands, Norway and United Kingdom. Frequent co-authors include Godefridus J. Peters, Finn Myhren, Hans R. Hendriks, Andries M. Bergman, Wenche Rasch, Øystein Fodstad, Iduna Fichtner, Frank Lyko, Roland Andersson and Petter‐Arnt Hals. Their work appears in journals such as Nucleosides Nucleotides & Nucleic Acids, Cancer Research, Molecular Cancer Therapeutics, Investigational New Drugs and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.